Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 95

Results For "NSE"

2392 News Found

Suven to acquire a majority stake in CDMO player ‘Sapala Organics’
News | June 14, 2024

Suven to acquire a majority stake in CDMO player ‘Sapala Organics’

Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies


Schneider Electric launches EcoStruxure for life science segment
Sustainability | June 11, 2024

Schneider Electric launches EcoStruxure for life science segment

Accelerating sustainability in Indian pharma industry


Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis
Clinical Trials | June 09, 2024

Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis

New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH


Gavi outlines plans to support access to new vaccines
News | June 09, 2024

Gavi outlines plans to support access to new vaccines

The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030


Borosil Scientific debuts on stock exchange
News | June 08, 2024

Borosil Scientific debuts on stock exchange

This strategic decision will unlock significant value for our scientific and industrial products business


AbbVie announces positive results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine for high FR? expressing platinum-sensitive ovarian cancer
Clinical Trials | June 07, 2024

AbbVie announces positive results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine for high FR? expressing platinum-sensitive ovarian cancer

PICCOLO trial met its primary endpoint of objective response rate (ORR)


Jemperli trial continues to show positive results for deficient (dMMR) rectal cancer
Clinical Trials | June 06, 2024

Jemperli trial continues to show positive results for deficient (dMMR) rectal cancer

Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response


GSK disagrees with ruling by the Delaware State Court on Zantac (ranitidine) litigation
News | June 06, 2024

GSK disagrees with ruling by the Delaware State Court on Zantac (ranitidine) litigation

Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims


Health Ministry and Defence Ministry ink MoU to set up dedicated Tele MANAS cell for armed forces
Policy | June 06, 2024

Health Ministry and Defence Ministry ink MoU to set up dedicated Tele MANAS cell for armed forces

The special Tele MANAS cell to serve as a dedicated mental health assistance helpline for all Armed Forces beneficiaries across country


Merck's oncology pipeline of DDRi and ADC poised to advance cancer treatment
Clinical Trials | June 04, 2024

Merck's oncology pipeline of DDRi and ADC poised to advance cancer treatment

Merck shared updates on the company’s oncology pipeline and focused R&D approach